Sg Americas Securities, LLC Harvard Bioscience Inc Transaction History
Sg Americas Securities, LLC
- $24.4 Billion
- Q4 2024
A detailed history of Sg Americas Securities, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 17,161 shares of HBIO stock, worth $24,711. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,161
Previous 13,409
27.98%
Holding current value
$24,711
Previous $36,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HBIO
# of Institutions
97Shares Held
31.5MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$4.09 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$3.99 Million0.44% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.72MShares$3.91 Million0.87% of portfolio
-
Amh Equity LTD2.5MShares$3.6 Million5.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$3.1 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $60M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...